Optimal Dosing of Prazosin for PTSD
The optimal dose of prazosin for PTSD is typically 1-10+ mg, starting at 1 mg at bedtime and titrating up by 1-2 mg every 3-7 days until symptom improvement is achieved. 1
Dosing Protocol
Initial Dosing and Titration
- Start with 1 mg at bedtime
- Titrate upward by 1-2 mg every 3-7 days
- Monitor for orthostatic hypotension, especially after the first dose
- Typical effective dose range: 1-10+ mg 1
Population-Specific Dosing
- Military/combat-related PTSD may require higher doses:
Dosing Schedule
- Consider twice-daily dosing for some patients 1
- For twice-daily regimens, a common approach is:
- Lower dose in the morning (e.g., 4-5 mg for men, 1-2 mg for women)
- Higher dose at bedtime (e.g., 15-20 mg for men, 7-10 mg for women) 3
Efficacy Considerations
- Prazosin has Level A evidence for PTSD-related nightmares 1
- Response typically seen within weeks 1
- Doses higher than 20 mg usually do not increase efficacy for most patients 1
- Treatment-resistant cases may require higher doses to achieve symptom control 4
Monitoring and Side Effects
- Evaluate orthostatic hypotension after the first dose
- Monitor blood pressure regularly during titration
- Assess treatment response after 4-6 weeks at maximum tolerated dose 1
- Common side effects include first-dose hypotension, dizziness, and sedation
Important Considerations
- Prazosin is particularly effective for PTSD-related nightmares and sleep disturbances
- For comprehensive PTSD management, consider combining with:
Common Pitfalls to Avoid
- Underdosing prazosin (inadequate symptom control)
- Failing to monitor blood pressure during titration
- Discontinuing treatment prematurely before adequate trial
- Not considering twice-daily dosing when nightmares return in latter half of sleep 1
- Using single nighttime dosing when daytime symptoms are also problematic
Alternative Considerations
- For patients who cannot tolerate prazosin, doxazosin may be considered as an alternative:
- Longer half-life requiring only once-daily dosing
- Available in extended-release form (GITS) allowing higher initial doses (4 mg/day)
- May improve adherence due to simplified dosing schedule 5